“Formulation and Development of HA BSA Coated NLC Containing Fisetin and Flavokawain A for the Treatment of Lung Carcinoma”. 2025. Journal of Carcinogenesis 24 (8s): 553-62. https://doi.org/10.64149/J.Carcinog.24.8s.553-562.